Skip to content

Role of visual therapy in children with cerebral visual impairment

Rehabilitative effectiveness of visuo-stimulation, visuo-motor and visuo-perceptual learning interventions in improving neuro-visuo-cognitive behaviour in children with CVI compared to standard care: A randomised control pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048114
Enrollment
60
Registered
2022-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P039- Newborn affected by complication of labor and delivery, unspecified

Interventions

Intervention1: Visual Therapy (visual stimulation, visuomotor and visuoperceptual learning interventions): Intervention- a structured training Various visual stimulation exercises will be explained at
additionally, educational videos will be shared for other caregivers at home not visiting It will be dividd into three parts: 1) Building visual behabiour like visual attention (VS) excercise using b

Sponsors

No sponsor
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria includes 1. patients with history and documentation of perinatal asphyxia, periventricular leukomalacia, hypoglycemia, perinatal infections, genetic, metabolic, hydrocephalus, or structural causes or 2. documented perinatal brain damage confirmed by a pediatric neurologist along with 3. MRI evidence of brain injury in a pattern typical of hypoxic-ischemic encephalopathy (HIE) including peri-ventricular leukomalacia (PVL) 4. problems in visual functioning (corroborated by results of functional vision assessment) or atypical neuro-visuo-behavior or visual perceptual or cognitive dysfunction on CVI inventory questionnaire and 5. confirmed on examination with at least 2 or more of the following: a) Deficit or impaired visual inattention, fixation, or inability to follow objects; b)Deficit visual guided reach or visual guidance of upper limbs (inability to reach out or hold a toy or difficulty in picking up a toy); c) Deficit visual communication/search/curiosity/ spatial orientation; d)Deficit visual processing like recognition of face/objects/facial expression or Difficulty with clutter

Exclusion criteria

Exclusion criteria: • Children with pediatric cataracts, corneal pathologies, retinal pathologies, or dense amblyopia responsible for low vision • Retinopathy of prematurity of grade 4 or 5, and major ROP sequelae like falciform fold involving disc or macula nonresolving macular bleed, vitreous hemorrhage assessed by a paediatric ophthalmologist • Children with epileptic spasms, electroclinical epileptic encephalopathy, seizure frequency of more than one/month in the past 3 months or patients using anti-epileptic vigabatrin • Children with debilitating illnesses requiring immediate attention • Children whose caregivers refuse to participate in the study • Autistic children

Design outcomes

Primary

MeasureTime frame
Primary outcome is improvement in FUNCTIONAL VISION in terms of 1. improvement in visual acuity, 2. visual attention (attention span, reaction time and number of orienting responses), 3. achieving steadiness of visual fixation, 4. improvement in visual communication, 5. improvement in visual guidance of limbs or visuomotor tasks 6. improvement in visual perception including cognition, recognition Timepoint: outcome will be assessed at the end of 1 year

Secondary

MeasureTime frame
â?¢ Imaging findings and correlation of imaging findings with clinical findings â?¢ pre and post electrophysiologic findings (Improvement in P100 latency) findings and correlation of imaging findings with clinical findingsTimepoint: at end of 1 year

Countries

India

Contacts

Public ContactDhara Sardhara

Post Graduate Institute of Medical Education and Research

shwets84omns@yahoo.com9990909575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026